Hemangioendothelioma: Difference between revisions

Jump to navigation Jump to search
← Older edit
VisualWikitext
Maria Villarreal (talk | contribs)
CMEUser, nocaptcha, nukepages, Administrators
7,149 edits
Farima Kahe (talk | contribs)
Bureaucrats, bureaucrats, nocaptcha, Administrators
4,723 edits
No edit summary
 
(33 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{SI}}                                                                 
{{SI}}                                                                 
{{CMG}} {{AE}} {{MV}}
{{CMG}}; {{AE}} {{MV}}
   
   
{{SK}} Infantile hemangioendothelioma; Kaposiform hemangioendothelioma; Retiform hemangioendothelioma; Epithelioid hemangioendothelioma
{{SK}} Infantile hemangioendothelioma; Kaposiform hemangioendothelioma; Retiform hemangioendothelioma; Epithelioid hemangioendothelioma; Dabska tumor
   
   
==Overview==
==Overview==
 
Hemangioendothelioma is a rare group of mesenchymal vascular neoplasms. Hemangioendotheliomas commonly present with an enlarging mass and have been reported in the [[head]], [[neck]], [[lungs]], [[lymph nodes]], [[pleura]], [[retroperitoneum]], or [[stomach]]. Hemangioendotheliomas may be [[benign]] or [[malignant]] and tend to occur around medium to large [[venous]] structures. Hemangioendothelioma may be classified into 4 groups including epitheloid hemangioendothelioma (most common), [[kaposiform hemangioendothelioma]], retiform hemangioendothelioma, and [[infantile hemangioendothelioma]]. The prevalence of hemangioendothelioma is approximately 1 per 100,000 individuals worldwide.
'''Hemangioendothelioma''' is a rare group of [[benign]] or [[malignant]] vascular neoplasms. Hemangioendotheliomas commonly present with an enlarging mass and have been reported in the [[head]] and [[neck]], [[intestines]], [[lungs]], [[lymph nodes]], [[pleura]], [[retroperitoneum]],or [[stomach]]. Surgical [[resection]], [[radiotherapy]], and [[chemotherapy]] is the treatment of choice for hemangioendothelioma.
The majority of patients with hemangioendothelioma are symptomatic at the time of diagnosis.<ref name="pmid3303234">{{cite journal |vauthors=Weiss SW, Ishak KG, Dail DH, Sweet DE, Enzinger FM |title=Epithelioid hemangioendothelioma and related lesions |journal=Semin Diagn Pathol |volume=3 |issue=4 |pages=259–87 |year=1986 |pmid=3303234 |doi= |url=}}</ref> Early clinical features of hemangioendothelioma are often unspecific and may include [[abdominal pain]], mass, [[weight loss]], or [[fatigue]]. On [[CT scan]], characteristic findings of [[hepatic]] hemangioendothelioma may include multiple hypo-attenuating lesions in both hepatic lobes which coalesce to form larger confluent hypo-attenuating regions in a peripheral or subcapsular distribution, halo or target pattern of enhancement in larger lesions, and a subcapsular lesion (with capsular retraction). Surgical [[resection]], [[radiotherapy]], and [[chemotherapy]] are often the treatment of choice for hemangioendothelioma.


==Historical Perspective==
==Historical Perspective==
*Hemangioendothelioma was first described by Sharon Weiss, an American pathologist, in 1986.
*Hemangioendothelioma was first described by Dr. Sharon Weiss, MD, an American pathologist, in 1986.<ref name="wiki">Hemangioendothelioma. Wikipedia. https://en.wikipedia.org/wiki/Hemangioendothelioma Accessed on April 22, 2016</ref>


==Classification==
==Classification==
*Hemangioendothelioma may be classified into 4 groups:
*Hemangioendothelioma may be classified into 4 groups:<ref name="pmid3303234">{{cite journal |vauthors=Weiss SW, Ishak KG, Dail DH, Sweet DE, Enzinger FM |title=Epithelioid hemangioendothelioma and related lesions |journal=Semin Diagn Pathol |volume=3 |issue=4 |pages=259–87 |year=1986 |pmid=3303234 |doi= |url=}}</ref>
:*Epithelioid hemangioendothelioma
 
:*Epithelioid hemangioendothelioma (most common)
:*[[Kaposiform hemangioendothelioma]]
:*[[Kaposiform hemangioendothelioma]]
:*Retiform hemangioendothelioma
:*Retiform hemangioendothelioma
:*[[Infantile hemangioendothelioma]]
:*[[Infantile hemangioendothelioma]]
::*Type I
::*Type I
:::*Multiple vascular channels  
:::*Multiple vascular channels
:::*Formed by an immature endothelial lining
:::*Formed by an immature endothelial lining
:::*Stromal separation from bile ductules
:::*[[Stromal]] separation from bile ductules
::*Type II:  
::*Type II:  
:::*Disorganized appearance and hypercellular
:::*Disorganized appearance and hypercellular
:::*There are no bile ductules
:::*Bile ductules absent


==Pathophysiology==
==Pathophysiology==
*The pathogenesis of hemangioendothelioma is characterized by  
*The pathogenesis of hemangioendothelioma is characterized by [[epithelioid]]-like features.<ref name="pmid3303234">{{cite journal |vauthors=Weiss SW, Ishak KG, Dail DH, Sweet DE, Enzinger FM |title=Epithelioid hemangioendothelioma and related lesions |journal=Semin Diagn Pathol |volume=3 |issue=4 |pages=259–87 |year=1986 |pmid=3303234 |doi= |url=}}</ref>
*Hemangioendotheliomas tend to occur around medium to large venous structures.
*Hemangioendotheliomas tend to occur around medium to large [[venous]] structures.<ref name="pmid3303234">{{cite journal |vauthors=Weiss SW, Ishak KG, Dail DH, Sweet DE, Enzinger FM |title=Epithelioid hemangioendothelioma and related lesions |journal=Semin Diagn Pathol |volume=3 |issue=4 |pages=259–87 |year=1986 |pmid=3303234 |doi= |url=}}</ref>
*There are no genetic mutations associated with the development of hemangioendothelioma.  
*There are no genetic [[Mutation|mutations]] associated with the development of hemangioendothelioma.
*On gross pathology, characteristic findings of hemangioendothelioma, include:  
*On gross pathology, characteristic findings of hemangioendothelioma include:  
:*No hallmark features
:*No hallmark features
:*Size may range up to 18 cm.
:*Size may range up to 18 cm  
*On microscopic histopathological analysis, characteristic findings of hemangioendothelioma, include:
*On microscopic [[histopathological]] analysis, characteristic findings of hemangioendothelioma include:<ref name="wiki">Hemangioendothelioma. Wikipedia. https://en.wikipedia.org/wiki/Hemangioendothelioma Accessed on April 22, 2016</ref><ref name="wjkjki">Hemangioendothelioma. Libre Pathology. https://librepathology.org/wiki/Infantile_hepatic_hemangioendothelioma Accessed on April 22, 2016</ref>
:*Large epithelioid perivascular cells
 
:*Abundant pale eosinophilic cytoplasm
:*Large, [[epithelioid]], perivascular cells
:*Cytoplasmic vacuolation (some cells) (also known as "blister cells") - key feature.
:*Abundant, pale, [[eosinophilic]] [[cytoplasm]]
:*May form lumen and have red blood cells within
:*[[Cytoplasmic]] vacuolation (some cells) (also known as "blister cells"), a key distinguishing feature
:*Vesicular nucleus with prominent nucleolus in some cells
:*May form [[lumen]] and contain [[red blood cells]]
:*Tuft-like projections into capillaries.
:*Vesicular nucleus with prominent [[nucleolus]] in some cells
:*Tuft-like projections into [[capillaries]]
 
'''Papillary intralymphatic hemangioendothelioma'''
'''Papillary intralymphatic hemangioendothelioma'''
:*Papillary tufts
 
:*Central hyaline core lined by hobnail-like endothelial cells protruding into the lumina
:*[[Papillary]] tufts
:*Central [[hyaline]] core lined by hobnail-like [[endothelial cells]] protruding into the lumina
'''Retiform hemangioendothelioma'''
'''Retiform hemangioendothelioma'''
:*Infiltrative neoplasm composed of elongated arborizing vessels
:*Infiltrative [[neoplasm composed]] of elongated, arborizing vessels
:*Arranged in an anastomosing pattern
:*Arranged in an anatomizing pattern
:*Lined by a single layer of "hobnail-like" endothelial cells (protrude within the narrow lumina)
:*Lined by a single layer of "hobnail-like" endothelial cells (protrude within the narrow lumina)
'''Kaposiform hemangioendothelioma'''
'''Kaposiform hemangioendothelioma'''
:*Composed of several solid poorly circumscribed nodules
 
:*Nodules composed of a mixture of small capillaries and solid lobules
:*Composed of several solid, poorly circumscribed [[nodules]]
::*Nodules composed of a mixture of small capillaries and solid lobules
:*Arranged in a glomeruloid pattern
:*Arranged in a glomeruloid pattern


*On immunohistochemistry, characteristic findings of hemangioendothelioma, include:
*On immunohistochemistry, characteristic findings of hemangioendothelioma include:<ref name="pmid3303234">{{cite journal |vauthors=Weiss SW, Ishak KG, Dail DH, Sweet DE, Enzinger FM |title=Epithelioid hemangioendothelioma and related lesions |journal=Semin Diagn Pathol |volume=3 |issue=4 |pages=259–87 |year=1986 |pmid=3303234 |doi= |url=}}</ref>
:*Positive CD31  
:*Positive [[CD31]]
:*Positive CD34  
:*Positive [[CD34]]
:*Positive Factor VIII
:*Positive [[Factor VIII]]


==Causes==
==Causes==
*Common causes of hemangioendothelioma, include:
*There are no established causes for hemangioendothelioma.<ref name="wjkjki">Hemangioendothelioma. Libre Pathology. https://librepathology.org/wiki/Infantile_hepatic_hemangioendothelioma Accessed on April 22, 2016</ref>
 
==Differentiating Hemangioendothelioma from Other Diseases==
*Hemangioendothelioma must be differentiated from other diseases that cause a hypervascular mass, or [[abdominal pain]], such as:<ref name="pmid3303234">{{cite journal |vauthors=Weiss SW, Ishak KG, Dail DH, Sweet DE, Enzinger FM |title=Epithelioid hemangioendothelioma and related lesions |journal=Semin Diagn Pathol |volume=3 |issue=4 |pages=259–87 |year=1986 |pmid=3303234 |doi= |url=}}</ref><ref name="radio">Hemangioendothelioma. Radiopedia. http://radiopaedia.org/articles/epithelioid-haemenagioendothelioma Accessed on April 22, 2016</ref>
:*[[Hepatoblastoma]]
:*[[Hemangioma]]
:*[[Angiosarcoma]]
:*[[Gallbladder cancer|Colangiocarcinoma]]


==Differentiating hemangioendothelioma from other Diseases==
*Hemangioendothelioma must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as:
:*Hepatoblastoma
:*Hemangioma
:*Angiosarcoma
:*
==Epidemiology and Demographics==
==Epidemiology and Demographics==
* The prevalence of hemangioendothelioma is approximately [number or range] per 100,000 individuals worldwide.
*Hemangioendothelioma is very rare. The [[prevalence]] of hemangioendothelioma is approximately 1 per 100,000 individuals worldwide.<ref name="radio">Hemangioendothelioma. Radiopedia. http://radiopaedia.org/articles/epithelioid-haemenagioendothelioma Accessed on April 22, 2016</ref>
* In [year], the incidence of hemangioendothelioma was estimated to be [number or range] cases per 100,000 individuals in [location].
   
   
===Age===
===Age===
*Patients of all age groups may develop hemangioendothelioma.
*Patients of all age groups may develop hemangioendothelioma.
 
*Hemangioendothelioma is more commonly observed among patients aged [age range] years old.
*Hemangioendothelioma is more commonly observed among [elderly patients/young patients/children].
===Gender===
===Gender===
*Hemangioendothelioma affects men and women equally.
*Hemangioendothelioma affects men and women equally.
Line 83: Line 85:


==Risk Factors==
==Risk Factors==
*Common risk factors in the development of hemangioendothelioma, include:
*Common [[risk factors]] in the development of hemangioendothelioma include:<ref name="pmid3303234">{{cite journal |vauthors=Weiss SW, Ishak KG, Dail DH, Sweet DE, Enzinger FM |title=Epithelioid hemangioendothelioma and related lesions |journal=Semin Diagn Pathol |volume=3 |issue=4 |pages=259–87 |year=1986 |pmid=3303234 |doi= |url=}}</ref>
:*Oral contraceptives
:*[[Oral contraceptive|Oral contraceptives]]
:*Polyvinyl chloride
:*[[Polyvinyl chloride]]


== Natural History, Complications and Prognosis==
== Natural History, Complications and Prognosis==
*The majority of patients with hemangioendothelioma are symptomatic at the time of diagnosis.<ref name="pmid3303234">{{cite journal |vauthors=Weiss SW, Ishak KG, Dail DH, Sweet DE, Enzinger FM |title=Epithelioid hemangioendothelioma and related lesions |journal=Semin Diagn Pathol |volume=3 |issue=4 |pages=259–87 |year=1986 |pmid=3303234 |doi= |url=}}</ref>
*The majority of patients with hemangioendothelioma are symptomatic at the time of [[diagnosis]].<ref name="pmid3303234">{{cite journal |vauthors=Weiss SW, Ishak KG, Dail DH, Sweet DE, Enzinger FM |title=Epithelioid hemangioendothelioma and related lesions |journal=Semin Diagn Pathol |volume=3 |issue=4 |pages=259–87 |year=1986 |pmid=3303234 |doi= |url=}}</ref>
*Early clinical features will depend on the subtype of hemangioendothelioma. Common clinical features, include:
*Early clinical features of hemangioendothelioma are often unspecific (e.g., [[abdominal pain]], mass, [[weight loss]], or [[fatigue]]).
 
*If left untreated, the majority of patients with hemangioendothelioma may progress to develop [[metastases]].  
*If left untreated, the majority of patients with hemangioendothelioma may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
*Common [[complications]] of hemangioendothelioma include:<ref name="wjkjki">Hemangioendothelioma. Libre Pathology. https://librepathology.org/wiki/Infantile_hepatic_hemangioendothelioma Accessed on April 22, 2016</ref>
*Common complications of hemangioendothelioma, include:
:*[[Hepatic failure]]
 
:*Multi-organ failure
*Prognosis is generally poor, and the 5-­year survival rate of patients with hemangioendothelioma is approximately 55%
:*[[Heart failure]]
*Prognosis is generally poor, and the 5-­year [[survival rate]] of patients with hemangioendothelioma is approximately 55%.<ref name="radio">Hemangioendothelioma. Radiopedia. http://radiopaedia.org/articles/epithelioid-haemenagioendothelioma Accessed on April 22, 2016</ref>
**Infantile hepatic hemangioendothelioma has a good [[prognosis]].<ref name="wjkjki">Hemangioendothelioma. Libre Pathology. https://librepathology.org/wiki/Infantile_hepatic_hemangioendothelioma Accessed on April 22, 2016</ref>


== Diagnosis ==
== Diagnosis ==
=== Symptoms ===
*Hemangioendothelioma is usually [[asymptomatic]].
*[[Symptoms]] of hemangioendothelioma may include:<ref name="wjkjki">Hemangioendothelioma. Libre Pathology. https://librepathology.org/wiki/Infantile_hepatic_hemangioendothelioma Accessed on April 22, 2016</ref>
:*[[Abdominal pain]]
:*[[Fatigue]]


=== Symptoms ===
*Hemangioendothelioma is usually asymptomatic.
*Symptoms of hemangioendothelioma may include the following:
:*[symptom 1]
:*[symptom 2]
:*[symptom 3]
:*[symptom 4]
:*[symptom 5]
:*[symptom 6]
=== Physical Examination ===
=== Physical Examination ===
*Patients with hemangioendothelioma usually may be well-appearing.
*Patients with hemangioendothelioma usually may be well-appearing.
*Physical examination may be remarkable for:
*[[Physical examination]] may be remarkable for:<ref name="radio">Hemangioendothelioma. Radiopedia. http://radiopaedia.org/articles/epithelioid-haemenagioendothelioma Accessed on April 22, 2016</ref>
:*Large mass
:*[[Palpation]]
:*[finding 2]
:*Large [[abdominal mass]]
:*[[Hepatomegaly]]


=== Laboratory Findings ===
=== Laboratory Findings ===
Line 119: Line 118:


===Imaging Findings===
===Imaging Findings===
*On CT, characteristic findings of hemangioendothelioma, include:  
*On [[X-ray]], characteristic findings of hemangioendothelioma include nonspecific soft tissue mass.
'''Hepatic Hemangioendothelioma'''
:*When involving bone, hemangioendotheliomas are predominantly [[lytic]] and may mimic hemangiomas with a course honeycomb appearance
 
*On [[CT scan]], characteristic findings of hemangioendothelioma include:<ref name="radio">Hemangioendothelioma. Radiopedia. http://radiopaedia.org/articles/epithelioid-haemenagioendothelioma Accessed on April 22, 2016</ref>
:'''Hepatic Hemangioendothelioma'''
*Nonspecific soft tissue mass with [[density]] similar to muscle, but demonstrates bright [[contrast]] enhancement.
 
:*Multiple hypo-attenuating lesions in both hepatic lobes
:*Multiple hypo-attenuating lesions in both hepatic lobes
:*That coalesce to form larger confluent hypo-attenuating regions in a peripheral or subcapsular distribution  
:*Lesions coalesce to form larger confluent hypo-attenuating regions in a peripheral or subcapsular distribution  
:*Halo or target pattern of enhancement in larger lesions
:*Halo or target pattern of enhancement in larger lesions
:*Subcapsular lesion often present with capsular retraction
:*Subcapsular lesion often present with capsular [[retraction]]
:*Located in a predominantly peripheral distribution, with coalescence as individual nodules.
:*Located in a predominantly peripheral distribution, with coalescence as individual nodules
:*Honeycomb appearance


*On MRI, characteristic findings of hemangioendothelioma, include:  
*On [[MRI]], characteristic findings of hemangioendothelioma include:<ref name="wjkjki">Hemangioendothelioma. Libre Pathology. https://librepathology.org/wiki/Infantile_hepatic_hemangioendothelioma Accessed on April 22, 2016</ref><ref name="radio">Hemangioendothelioma. Radiopedia. http://radiopaedia.org/articles/epithelioid-haemenagioendothelioma Accessed on April 22, 2016</ref>
'''Hepatic Hemangioendothelioma'''
:'''Hepatic Hemangioendothelioma'''
:*T1: hypointense lesions relative to normal liver parenchyma on unenhanced T1-weighted images
:*T1: hypointense lesions relative to normal liver [[parenchyma]] on unenhanced T1-weighted images
:*T2: heterogeneously increased signal intensity
:*T2: heterogeneously increased signal intensity
:*C+ (Gd): some lesions demonstrate either a peripheral halo or a target-type enhancement pattern after administration of a gadolinium-based contrast agent, with occasional observation of a thin peripheral hypointense rim
:*C+ (Gd): some lesions demonstrate either a peripheral halo or a target-type enhancement pattern after administration of a [[gadolinium]]-based contrast agent, with occasional observation of a thin peripheral hypointense rim
 
*On [[angiography]], characteristic findings of hemangioendothelioma include dense, well-circumscribed areas of enhancement with early draining [[Vein|veins]] and shunting.


== Treatment ==
== Treatment ==
=== Medical Therapy ===
=== Medical Therapy ===
*There is no treatment for hemangioendothelioma; the mainstay of therapy is supportive care.
*There is no treatment for hemangioendothelioma; the mainstay of therapy is supportive care.
*Common therapies for hemangioendothelioma may include:
:*[[Interferon]]
:*[[Sorafenib]]
:*[[Corticosteroids]]
:*[[Paclitaxel]]
:*[[Thalidomide]]
:*[[Doxorubicin]]
*[[Radiation therapy]] for hemangioendothelioma remains unclear.


=== Surgery ===
=== Surgery ===
*Surgery is the mainstay of therapy for hemangioendothelioma.
*Surgery is the mainstay of [[therapy]] for hemangioendothelioma.<ref name="wjkjki">Hemangioendothelioma. Libre Pathology. https://librepathology.org/wiki/Infantile_hepatic_hemangioendothelioma Accessed on April 22, 2016</ref>
*The recurrence rate after surgery of hemangioendothelioma. is approximately 40%  
*The recurrence rate after [[surgery]] of hemangioendothelioma is approximately 40%.
*
 
=== Prevention ===
=== Prevention ===
*There are no primary preventive measures available for hemangioendothelioma.
*There are no primary preventive measures available for hemangioendothelioma.
Line 148: Line 162:
{{Reflist|2}}
{{Reflist|2}}
   
   
[[Category: Oncology]]
[[Category:Oncology]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Hematology]]
[[Category:Immunology]]
[[Category:Vascular medicine]]

Latest revision as of 16:01, 23 October 2019

WikiDoc Resources for Hemangioendothelioma

Articles

Most recent articles on Hemangioendothelioma

Most cited articles on Hemangioendothelioma

Review articles on Hemangioendothelioma

Articles on Hemangioendothelioma in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hemangioendothelioma

Images of Hemangioendothelioma

Photos of Hemangioendothelioma

Podcasts & MP3s on Hemangioendothelioma

Videos on Hemangioendothelioma

Evidence Based Medicine

Cochrane Collaboration on Hemangioendothelioma

Bandolier on Hemangioendothelioma

TRIP on Hemangioendothelioma

Clinical Trials

Ongoing Trials on Hemangioendothelioma at Clinical Trials.gov

Trial results on Hemangioendothelioma

Clinical Trials on Hemangioendothelioma at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hemangioendothelioma

NICE Guidance on Hemangioendothelioma

NHS PRODIGY Guidance

FDA on Hemangioendothelioma

CDC on Hemangioendothelioma

Books

Books on Hemangioendothelioma

News

Hemangioendothelioma in the news

Be alerted to news on Hemangioendothelioma

News trends on Hemangioendothelioma

Commentary

Blogs on Hemangioendothelioma

Definitions

Definitions of Hemangioendothelioma

Patient Resources / Community

Patient resources on Hemangioendothelioma

Discussion groups on Hemangioendothelioma

Patient Handouts on Hemangioendothelioma

Directions to Hospitals Treating Hemangioendothelioma

Risk calculators and risk factors for Hemangioendothelioma

Healthcare Provider Resources

Symptoms of Hemangioendothelioma

Causes & Risk Factors for Hemangioendothelioma

Diagnostic studies for Hemangioendothelioma

Treatment of Hemangioendothelioma

Continuing Medical Education (CME)

CME Programs on Hemangioendothelioma

International

Hemangioendothelioma en Espanol

Hemangioendothelioma en Francais

Business

Hemangioendothelioma in the Marketplace

Patents on Hemangioendothelioma

Experimental / Informatics

List of terms related to Hemangioendothelioma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Synonyms and keywords: Infantile hemangioendothelioma; Kaposiform hemangioendothelioma; Retiform hemangioendothelioma; Epithelioid hemangioendothelioma; Dabska tumor

Overview

Hemangioendothelioma is a rare group of mesenchymal vascular neoplasms. Hemangioendotheliomas commonly present with an enlarging mass and have been reported in the head, neck, lungs, lymph nodes, pleura, retroperitoneum, or stomach. Hemangioendotheliomas may be benign or malignant and tend to occur around medium to large venous structures. Hemangioendothelioma may be classified into 4 groups including epitheloid hemangioendothelioma (most common), kaposiform hemangioendothelioma, retiform hemangioendothelioma, and infantile hemangioendothelioma. The prevalence of hemangioendothelioma is approximately 1 per 100,000 individuals worldwide. The majority of patients with hemangioendothelioma are symptomatic at the time of diagnosis.[1] Early clinical features of hemangioendothelioma are often unspecific and may include abdominal pain, mass, weight loss, or fatigue. On CT scan, characteristic findings of hepatic hemangioendothelioma may include multiple hypo-attenuating lesions in both hepatic lobes which coalesce to form larger confluent hypo-attenuating regions in a peripheral or subcapsular distribution, halo or target pattern of enhancement in larger lesions, and a subcapsular lesion (with capsular retraction). Surgical resection, radiotherapy, and chemotherapy are often the treatment of choice for hemangioendothelioma.

Historical Perspective

  • Hemangioendothelioma was first described by Dr. Sharon Weiss, MD, an American pathologist, in 1986.[2]

Classification

  • Hemangioendothelioma may be classified into 4 groups:[1]
  • Type I
  • Multiple vascular channels
  • Formed by an immature endothelial lining
  • Stromal separation from bile ductules
  • Type II:
  • Disorganized appearance and hypercellular
  • Bile ductules absent

Pathophysiology

  • The pathogenesis of hemangioendothelioma is characterized by epithelioid-like features.[1]
  • Hemangioendotheliomas tend to occur around medium to large venous structures.[1]
  • There are no genetic mutations associated with the development of hemangioendothelioma.
  • On gross pathology, characteristic findings of hemangioendothelioma include:
  • No hallmark features
  • Size may range up to 18 cm

Papillary intralymphatic hemangioendothelioma

Retiform hemangioendothelioma

  • Infiltrative neoplasm composed of elongated, arborizing vessels
  • Arranged in an anatomizing pattern
  • Lined by a single layer of "hobnail-like" endothelial cells (protrude within the narrow lumina)

Kaposiform hemangioendothelioma

  • Composed of several solid, poorly circumscribed nodules
  • Nodules composed of a mixture of small capillaries and solid lobules
  • Arranged in a glomeruloid pattern
  • On immunohistochemistry, characteristic findings of hemangioendothelioma include:[1]

Causes

  • There are no established causes for hemangioendothelioma.[3]

Differentiating Hemangioendothelioma from Other Diseases

  • Hemangioendothelioma must be differentiated from other diseases that cause a hypervascular mass, or abdominal pain, such as:[1][4]

Epidemiology and Demographics

  • Hemangioendothelioma is very rare. The prevalence of hemangioendothelioma is approximately 1 per 100,000 individuals worldwide.[4]

Age

  • Patients of all age groups may develop hemangioendothelioma.

Gender

  • Hemangioendothelioma affects men and women equally.

Race

  • There is no racial predilection for hemangioendothelioma.

Risk Factors

Natural History, Complications and Prognosis

  • The majority of patients with hemangioendothelioma are symptomatic at the time of diagnosis.[1]
  • Early clinical features of hemangioendothelioma are often unspecific (e.g., abdominal pain, mass, weight loss, or fatigue).
  • If left untreated, the majority of patients with hemangioendothelioma may progress to develop metastases.
  • Common complications of hemangioendothelioma include:[3]
  • Prognosis is generally poor, and the 5-­year survival rate of patients with hemangioendothelioma is approximately 55%.[4]
    • Infantile hepatic hemangioendothelioma has a good prognosis.[3]

Diagnosis

Symptoms

Physical Examination

Laboratory Findings

  • There are no specific laboratory findings associated with hemangioendothelioma.

Imaging Findings

  • On X-ray, characteristic findings of hemangioendothelioma include nonspecific soft tissue mass.
  • When involving bone, hemangioendotheliomas are predominantly lytic and may mimic hemangiomas with a course honeycomb appearance
  • On CT scan, characteristic findings of hemangioendothelioma include:[4]
Hepatic Hemangioendothelioma
  • Nonspecific soft tissue mass with density similar to muscle, but demonstrates bright contrast enhancement.
  • Multiple hypo-attenuating lesions in both hepatic lobes
  • Lesions coalesce to form larger confluent hypo-attenuating regions in a peripheral or subcapsular distribution
  • Halo or target pattern of enhancement in larger lesions
  • Subcapsular lesion often present with capsular retraction
  • Located in a predominantly peripheral distribution, with coalescence as individual nodules
  • Honeycomb appearance
  • On MRI, characteristic findings of hemangioendothelioma include:[3][4]
Hepatic Hemangioendothelioma
  • T1: hypointense lesions relative to normal liver parenchyma on unenhanced T1-weighted images
  • T2: heterogeneously increased signal intensity
  • C+ (Gd): some lesions demonstrate either a peripheral halo or a target-type enhancement pattern after administration of a gadolinium-based contrast agent, with occasional observation of a thin peripheral hypointense rim
  • On angiography, characteristic findings of hemangioendothelioma include dense, well-circumscribed areas of enhancement with early draining veins and shunting.

Treatment

Medical Therapy

  • There is no treatment for hemangioendothelioma; the mainstay of therapy is supportive care.
  • Common therapies for hemangioendothelioma may include:

Surgery

  • Surgery is the mainstay of therapy for hemangioendothelioma.[3]
  • The recurrence rate after surgery of hemangioendothelioma is approximately 40%.

Prevention

  • There are no primary preventive measures available for hemangioendothelioma.

References

  1. ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 Weiss SW, Ishak KG, Dail DH, Sweet DE, Enzinger FM (1986). "Epithelioid hemangioendothelioma and related lesions". Semin Diagn Pathol. 3 (4): 259–87. PMID 3303234.
  2. ↑ 2.0 2.1 Hemangioendothelioma. Wikipedia. https://en.wikipedia.org/wiki/Hemangioendothelioma Accessed on April 22, 2016
  3. ↑ 3.0 3.1 3.2 3.3 3.4 3.5 3.6 Hemangioendothelioma. Libre Pathology. https://librepathology.org/wiki/Infantile_hepatic_hemangioendothelioma Accessed on April 22, 2016
  4. ↑ 4.0 4.1 4.2 4.3 4.4 4.5 Hemangioendothelioma. Radiopedia. http://radiopaedia.org/articles/epithelioid-haemenagioendothelioma Accessed on April 22, 2016
Retrieved from "https://www.wikidoc.org/index.php?title=Hemangioendothelioma&oldid=1585430"